Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

Search/

Search/

Loading…

CFO sold ~$38K of PBYI shares in the open market | OQRO

Home
Insider trades
Puma Biotechnology
CFO sold ~$38K of PBYI shares in the open market

Insider trade

CFO sold ~$38K of PBYI shares in the open market

Traded Jan 7, 2026 · Filed Jan 9, 2026

PBYPuma BiotechnologyPBYI

~$38K
Approx. value · 6,405 sh @ $5.88: 193K
Holds after · shares reported

Why it stands out

The CFO of Puma Biotechnology sold $38K of Puma Biotechnology shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 7, 2026
Reporting period: Not applicable
Filed with the SEC: Jan 9, 2026

CFO$25K–$100KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$37,655

Shares × reported transaction price

Timing vs results

62 days after results of Nov 6, 2025, 50 days before results of Feb 26, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001437749-26-000921
Filed / recorded: Jan 9, 2026, 6:14 AM UTC
Added to OQRO: Oct 7, 2026, 5:52 AM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: PUMA BIOTECHNOLOGY, INC.
Issuer CIK: 1401667
Ticker: PBYI
Reporting person: Maximo F Nougues
Relationship: Officer
Officer title: Chief Financial Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jan 7, 2026
Transaction code: S
Shares / units: 6,405
Price per share: $5.88
Acquired / disposed: Disposed (D)
Shares owned after: 193,284
Ownership form: Direct
Amendment: No

Footnotes from the filing

Adoption date of referenced 10b5-1(c) plan is: 12-14-2020

Around the same time

Alan H Auerbach (President and CEO) sold ~$99K of Puma Biotechnology

Scheduled in advanceFiled 9mo ago

Alan H Auerbach (President and CEO) sold ~$106K of Puma Biotechnology

Scheduled in advanceFiled 9mo ago

Douglas M Hunt (See Remarks) sold ~$23K of Puma Biotechnology

Scheduled in advanceFiled 9mo ago